Mannose antibody levels in gastric cancer patients (literature review and clinical and experimental study)

Cover Page

Cite item

Full Text

Abstract

Introduction. Glycans play an important role in the pathogenesis of malignant neoplasms, including stomach cancer. In recent years, the attention of many researchers has been drawn to mannose (Man) – hexose, which is an indispensable component of all N-chains of glycoproteins involved in both normal physiological and pathological processes.

Aim. To investigate the role of innate immunity factors and ways to influence them through mannose and mannose-containing glycans in gastric cancer patients.

Materials and methods. Data on the role of mannose – one of the key monosaccharides in the formation of glycoprotein N-chains – and its binding receptors (mannose receptor, mannose-binding lectin, antibodies) in gastric cancer since 2006 are presented. Levels of anti-glycan antibodies in blood serum samples of 235 gastric cancer patients and 76 healthy donors were evaluated using a glycochip.

Results. It has been shown that the level of IgM-class antibodies to Manβ – the core part of N-glycans – in gastric cancer patients is significantly lower compared to the donor group, regardless of age (p = 0.0001). To assess the effect of age on the levels of antiglycan antibodies, patients were divided into two subgroups – before and after 45 years. In the group under 45 years of age, significant differences in the levels of antiglycan antibodies to Manβ persisted, while significant differences in the levels of antiglycan antibodies to Manβ1-4GlcNAcβ were not observed. when comparing groups of patients and donors older than 45 years, the levels of antibodies to Manβ and Manβ1-4GlcNAcβ were significantly higher only in donors.

Conclusion. Deficiency of humoral immunity may be one of the key factors in the initiation and progression of carcinogenesis in humans. In our work, in patients with stomach cancer, we revealed a deficiency of antiglycan antibodies to Manβ and to Manβ1-4GlcNAcβ – core fragments of N-chains of glycoproteins, and the deficiency increased with age. The results of the study are a promising platform for further research aimed not only at studying the role of anti-mannose antibodies, but also at developing approaches to adoptive immunoprophylaxis.

About the authors

M. P. Nikulin

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

Author for correspondence.
Email: maximpetrovich@mail.ru
ORCID iD: 0000-0002-9608-4696

24 Kashirskoe Shosse, Moscow 115522

Russian Federation

N. V. Shilova

Shemyakin–Ovchinnikov Institute of bioorganic chemistry RAS

ORCID iD: 0000-0001-6003-071X

16 / 10 Miklukho-Maclay St., Moscow 117997

Russian Federation

A. D. Lipatnikov

Shemyakin–Ovchinnikov Institute of bioorganic chemistry RAS

ORCID iD: 0000-0003-2925-9924

16 / 10 Miklukho-Maclay St., Moscow 117997

Russian Federation

A. V. Semyanikhina

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

ORCID iD: 0000-0001-8783-8874

24 Kashirskoe Shosse, Moscow 115522

Russian Federation

I. S. Stilidi

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

ORCID iD: 0000-0002-5229-8203

24 Kashirskoe Shosse, Moscow 115522

Russian Federation

N. V. Bovin

Shemyakin–Ovchinnikov Institute of bioorganic chemistry RAS

ORCID iD: 0000-0001-8669-4477

16 / 10 Miklukho-Maclay St., Moscow 117997

Russian Federation

N. N. Tupitsyn

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

ORCID iD: 0000-0003-3966-128X

24 Kashirskoe Shosse, Moscow 115522

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-53039 от  04.03.2013.